Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations: 2010-2019

Historic Cash from Discontinued Operations for Ironwood Pharmaceuticals (IRWD) over the last 1 years, with Mar 2019 value amounting to $11.4 million.

  • Ironwood Pharmaceuticals' Cash from Discontinued Operations was N/A to $11.4 million in Q1 2019 from the same period last year, while for Mar 2019 it was $14.3 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2019, which is 3.76% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Cash from Discontinued Operations of $11.4 million as of Q1 2019, which was up 191.53% from $3.9 million recorded in Q4 2018.
  • Over the past 5 years, Ironwood Pharmaceuticals' Cash from Discontinued Operations peaked at $11.4 million during Q1 2019, and registered a low of $2.6 million during Q3 2018.
  • Over the past 2 years, Ironwood Pharmaceuticals' median Cash from Discontinued Operations value was $3.9 million (recorded in 2018), while the average stood at $6.0 million.